1. PERK 1/2 inhibit Caspase‐8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner. Issue 2 (20th November 2013) Authors: Mandal, Ranadip; Raab, Monika; Matthess, Yves; Becker, Sven; Knecht, Rainald; Strebhardt, Klaus Journal: Molecular oncology Issue: Volume 8:Issue 2(2014:Mar.) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sequential Cdk1 and Plk1 phosphorylation of caspase‐8 triggers apoptotic cell death during mitosis. Issue 3 (17th January 2014) Authors: Matthess, Yves; Raab, Monika; Knecht, Rainald; Becker, Sven; Strebhardt, Klaus Journal: Molecular oncology Issue: Volume 8:Issue 3(2014:May) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery. (January 2015) Authors: Strebhardt, Klaus; Becker, Sven; Matthess, Yves Journal: Expert opinion on drug discovery Issue: Volume 10:Number 1(2015:Jan.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗